COMMON TRANSCRIPTIONAL PROGRAMS AND THE ROLE OF CHEMOKINE (C-C MOTIF) LIGAND 20 (CCL20) IN CELL MIGRATION OF CHOLANGIOCARCINOMA

被引:3
作者
Maung, Hay Mar Win [1 ]
Chan-On, Waraporn [2 ]
Kunkeaw, Nawapol [3 ]
Khaenam, Prasong [1 ]
机构
[1] Mahidol Univ, Fac Med Technol, Ctr Standardizat & Prod Validat, Phutthamonthon Dist 73170, Nakhon Pathom, Thailand
[2] Mahidol Univ, Fac Med Technol, Ctr Res & Innovat, Phutthamonthon Dist 73170, Nakhon Pathom, Thailand
[3] Mahidol Univ, Inst Mol Biosci, Phutthamonthon Dist 73170, Nakhon Pathom, Thailand
来源
EXCLI JOURNAL | 2020年 / 19卷
关键词
CCL20; CCR6; cholangiocarcinoma (CCA); microarray; epithelial-mesenchymal transition (EMT); cell migration; EPITHELIAL-MESENCHYMAL TRANSITION; EXPRESSION; CANCER; CCR6; PROLIFERATION;
D O I
10.17179/excli2019-1893
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The incidence of cholangiocarcinoma (CCA) has risen in many countries, but there is still no appropriate screening and treatment available. The growing number of microarray data published todays can be a powerful resource for the discovery of biomarkers to tackle challenges in the management of CCA. This study analyzed multiple microarray datasets to identify the common transcriptional networks in CCA and select a possible biomarker for functional study in CCA cell lines. A systematic searching identified 4 microarray datasets from Gene Expression Omnibus (GEO) repository and PubMed articles.Differential expression analysis between tumor and normal tissues was performed in each dataset. In order to characterize the common expression pattern, differentially expressed genes (DEGs) from all datasets were combined and visualized by hierarchical clustering and heatmap. Gene enrichment analysis performed in each cluster revealed that over-expressed DEGs were enriched in cell cycle, cell migration and response to cytokines while under-expressed DEGs were enriched in metabolic processes such as oxidation-reduction, lipid, and drug. To explain tumor characteristics, genes enriched in cell migration and response to cytokines were further investigated. Among these genes, CCL20 was selected for functional study because its role has never been studied in CCA. Moreover, its signaling may be regulated by disrupting its only receptor, CCR6. Treatment with recombinant CCL20 induced higher cell migration and increased expression of N-cad. In contrast, knockdown of CCR6 by siRNA reduced cell migration ability and decreased N-cadherin level. Altogether, these results suggested the contribution of CCL20/CCR6 signaling in cell migration through epithelialmesenchymal transition process. Thus, CCL20/CCR6 signaling might be a target for the management of CCA.
引用
收藏
页码:154 / 166
页数:13
相关论文
共 31 条
  • [1] Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors
    Andersen, Jesper B.
    Spee, Bart
    Blechacz, Boris R.
    Avital, Itzhak
    Komuta, Mina
    Barbour, Andrew
    Conner, Elizabeth A.
    Gillen, Matthew C.
    Roskams, Tania
    Roberts, Lewis R.
    Factor, Valentina M.
    Thorgeirsson, Snorri S.
    [J]. GASTROENTEROLOGY, 2012, 142 (04) : 1021 - U552
  • [2] CCL20 neutralization by a monoclonal antibody in healthy subjects selectively inhibits recruitment of CCR6+ cells in an experimental suction blister
    Bouma, Gerben
    Zamuner, Stefano
    Hicks, Kirsty
    Want, Andrew
    Oliveira, Joao
    Choudhury, Arpita
    Brett, Sara
    Robertson, Darren
    Felton, Leigh
    Norris, Virginia
    Fernando, Disala
    Herdman, Michael
    Tarzi, Ruth
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (09) : 1976 - 1990
  • [3] The chemokine receptor CCR6 facilitates the onset of mammary neoplasia in the MMTV-PyMT mouse model via recruitment of tumor-promoting macrophages
    Boyle, Sarah T.
    Faulkner, Jessica W.
    McColl, Shaun R.
    Kochetkova, Marina
    [J]. MOLECULAR CANCER, 2015, 14
  • [4] Butler James A, 2016, Front Immunol, V7, P658, DOI 10.3389/fimmu.2016.00658
  • [5] TNF-α increases the membrane expression of the chemokine receptor CCR6 in thyroid tumor cells, but not in normal thyrocytes: potential role in the metastatic spread of thyroid cancer
    Coperchini, Francesca
    Pignatti, Patrizia
    Carbone, Andrea
    Bongianino, Rossana
    Di Buduo, Christian A.
    Leporati, Paola
    Croce, Laura
    Magri, Flavia
    Balduini, Alessandra
    Chiovato, Luca
    Rotondi, Mario
    [J]. TUMOR BIOLOGY, 2016, 37 (04) : 5569 - 5575
  • [6] chemokine/chemokine receptor pair CCL20/CCR6 in human colorectal malignancy: An overview
    Frick, Vilma Oliveira
    Rubie, Claudia
    Keilholz, Ulrich
    Ghadjar, Pirus
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (02) : 833 - 841
  • [7] Goral Vedat, 2017, Asian Pac J Cancer Prev, V18, P1469
  • [8] Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition
    Hou, Ke-Zhu
    Fu, Zhi-Qiang
    Gong, Hua
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (02) : 475 - 483
  • [9] CCR6 expression in colon cancer is associated with advanced disease and supports epithelial-to-mesenchymal transition
    Kapur, Neeraj
    Mir, Hina
    Clark, Clarence E., III
    Krishnamurti, Uma
    Beech, Derrick J.
    Lillard, James W.
    Singh, Shailesh
    [J]. BRITISH JOURNAL OF CANCER, 2016, 114 (12) : 1343 - 1351
  • [10] TGF-β signaling and epithelial-mesenchymal transition in cancer progression
    Katsuno, Yoko
    Lamouille, Samy
    Derynck, Rik
    [J]. CURRENT OPINION IN ONCOLOGY, 2013, 25 (01) : 76 - 84